Mumbai, Feb. 25 -- The key equity benchmarks continued to trade in positive territory, posting minor gains in morning trade. The Nifty traded above 22,550 mark. Media shares jumped after declining in ... Read More
Mumbai, Feb. 25 -- The firm added that this appointment is based on the recommendation of the nomination and remuneration committee. Dorababu Daparti is a highly accomplished banking professional wit... Read More
Mumbai, Feb. 25 -- According to media reports, Tata Capital's board approved its IPO on Tuesday. The offering will include 23 crore new shares and an offer for sale (OFS) from existing shareholders. ... Read More
Mumbai, Feb. 25 -- Alembic Pharmaceuticals announced that Sameer Khera (DIN: 00009317) has completed his second consecutive term of five years as an Independent Director and consequently ceases to be... Read More
Mumbai, Feb. 25 -- This pioneering agreement heralds a new era of rail infrastructure innovation, high-speed rail solutions, AI-powered predictive diagnostics, self-propelled wagons, and driverless fr... Read More
Mumbai, Feb. 25 -- This MoU establishes a partnership between MPPGCL and NTPC Green Energy in the renewable energy sector. The collaboration aims to develop renewable energy projects, including solar,... Read More
Mumbai, Feb. 25 -- RDB Real Estate Construction will hold a meeting of the Board of Directors of the Company on 3 March 2025. Published by HT Digital Content Services with permission from Capital Mar... Read More
Mumbai, Feb. 25 -- AK Spintex will hold a meeting of the Board of Directors of the Company on 1 March 2025. Published by HT Digital Content Services with permission from Capital Market.... Read More
Mumbai, Feb. 25 -- IIFL Finance will hold a meeting of the Board of Directors of the Company on 28 February 2025. Published by HT Digital Content Services with permission from Capital Market.... Read More
Mumbai, Feb. 25 -- YESINTEK is a biosimilar to Stelara (ustekinumab) and is one of the first biosimilar versions of Stelara to be introduced to the U.S. market. The biosimilar is approved for the tre... Read More